| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9034300 | GISKIT | Composition and method for medical imaging of body cavities |
Oct, 2030
(6 years from now) | |
| US9259494 | GISKIT | Composition and method for medical imaging of body cavities |
May, 2035
(11 years from now) | |
| US9849199 | GISKIT | Composition and method for medical imaging of body cavities |
Feb, 2036
(11 years from now) | |
Exem Foam Kit is owned by Giskit.
Exem Foam Kit contains Air Polymer-Type A.
Exem Foam Kit has a total of 3 drug patents out of which 0 drug patents have expired.
Exem Foam Kit was authorised for market use on 07 November, 2019.
Exem Foam Kit is available in foam;intrauterine dosage forms.
Exem Foam Kit can be used as use in sonohysterosalpinography to assess fallopian tube patency.
Drug patent challenges can be filed against Exem Foam Kit from 08 November, 2023.
The generics of Exem Foam Kit are possible to be released after 11 February, 2036.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Chemical Entity Exclusivity(NCE) | Nov 07, 2024 |
Drugs and Companies using AIR POLYMER-TYPE A ingredient
NCE-1 date: 08 November, 2023
Market Authorisation Date: 07 November, 2019
Treatment: Use in sonohysterosalpinography to assess fallopian tube patency
Dosage: FOAM;INTRAUTERINE
EXEM FOAM KIT family patents
